Rchr
J-GLOBAL ID：201401016364268817
Update date: Apr. 01, 2024
Tamura Takao
タムラ タカオ | Tamura Takao
Affiliation and department：
Homepage URL (1)：
http://kaken.nii.ac.jp/d/r/80324929.ja.html
Research field (3)：
Gastroenterology
, Tumor biology
, Clinical pharmacy
Research keywords (8)：
pancreatic cancer
, Esophageal Cancer
, Gastric cancer
, フッ化ピリミジン系
, がん化学療法
, colorectal cancer
, 代謝拮抗剤
, 適正使用
Research theme for competitive and other funds (1)：
- 2008 - 2010 Appropriate use of the oral fluoropyrimidine anticancer drugs in patients with colorectal cancer
Papers (141)：
-
Yoon-Koo Kang, Satoshi Morita, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, et al. Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2022. 25. 1. 207-217
-
Takahiro Kimura, Takayuki Takahama, Tomoko Wakasa, Shiori Adachi, Yusaku Akashi, Takao Tamura, Katsunari Yane. Role of debulking surgery in combination with immune therapy: A successfully treated case of locally advanced mucosal melanoma. Molecular and clinical oncology. 2022. 16. 1. 2-2
-
Tomono Kawase, Hiroshi Imamura, Masahiro Goto, Yutaka Kimura, Shugo Ueda, Jin Matsuyama, Kazuhiro Nishikawa, Naotoshi Sugimoto, Junya Fujita, Takao Tamura, et al. Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701. International journal of clinical oncology. 2021. 26. 10. 1871-1880
-
Narikazu Boku, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, Kun-Huei Yeh, et al. Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2021. 24. 4. 946-958
-
Hiromichi Nakajima, Shota Fukuoka, Toshiki Masuishi, Atsuo Takashima, Yosuke Kumekawa, Takeshi Kajiwara, Kentaro Yamazaki, Yuji Negoro, Masato Komoda, Akitaka Makiyama, et al. Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment. Frontiers in oncology. 2021. 11. 688709-688709
ｍore...
MISC (154)：
-
木村隆浩, 高濱隆幸, 足立詩織, 若狭朋子, 明石雄策, 田村孝雄, 家根旦有, 桝井貴史, 上村裕和, 山中敏彰, et al. 免疫療法における腫瘍縮小手術の役割-局所進行口腔粘膜悪性黒色腫の治療経験-. 日本頭頸部外科学会総会ならびに学術講演会プログラム・予稿集. 2022. 31st
-
高濱隆幸, 市村紀子, 岡部崇記, 明石雄策, 田村孝雄, 下吉都, 亀田啓介, 若狭朋子, 太田善夫, 山田秀和, et al. Multi-disciplinary collaboration on gene panel testing and review of factors in cases of unsuitable for gene profiling. 日本臨床腫瘍学会学術集会(CD-ROM). 2021. 18th
-
岡部嵩記, 明石雄策, 高濱隆幸, 福田浩平, 井上恵理, 李在俊, 岡嶋馨, 若狭朋子, 太田善夫, 田村孝雄. Analysis of patients who were resistant to durvalumab after chemoradiotherapy in stag3 non-small-cell lung cancer. 日本臨床腫瘍学会学術集会(CD-ROM). 2021. 18th
-
明石雄策, 岡部崇記, 高濱隆幸, 若狭朋子, 太田善夫, 田村孝雄. 当院におけるオンコマインDx Target TestマルチCDxシステムの使用経験と,ドライバー遺伝子陽性症例に関して. 日本臨床腫瘍学会学術集会(CD-ROM). 2021. 18th
-
Jin Matsuyama, Hisato Kawakami, Kazumasa Fujitani, Yusuke Akamaru, Shigeyuki Tamura, Shunji Endo, Yutaka Kimura, Youichi Makari, Takao Tamura, Naotoshi Sugimoto, et al. Comparing five-weekly S-1 plus cisplatin with tri-weekly capecitabine plus cisplatin in patients with HER2-negative recurrent gastric cancer after S-1 adjuvant therapy or chemotherapy naive advanced gastric cancer: A pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
ｍore...
Education (2)：
- 1991 - 1995 神戸大学大学院 医学研究科
- 1982 - 1988 Kobe University School of Medicine
Professional career (1)：
Work history (2)：
- 2008/06 - 2012/03 Kindai University Faculty of Medicine
- 2005/01 - 2008/05 Kobe University
Return to Previous Page
